Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
|
1 |
Annola K. |
Fetal Exposure to Food Carcinogens.
|
|
2 |
Annola K et al. |
Transplacental transfer of nitrosodimethylamine in perfused human placenta.
|
|
3 |
Bell JS et al. |
National utilization of transdermal fentanyl among community-dwelling older people in Finland.
|
|
4 |
Eriksson K et al. |
Fosphenytoin.
|
|
5 |
Hanzlíková M et al. |
The role of PEI structure and size in the PEI/liposome-mediated synergism of gene transfection.
|
|
6 |
Hartikainen S et al. |
Mahahaavalääkitys pienemmin kustannuksin.
|
|
7 |
Hautala E et al. |
Lääkehoidon arviointien kustannusvaikuttavuus iäkkäillä - mitä päätemuuttujia ja kustannuseriä tutkimuksissa on huomioitu (with English summary). Sosiaalifarmasian projektityö 2008-2009.
|
|
8 |
Immonen E et al. |
Responses of PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine) in MCF-7 cells are culture condition dependent.
|
|
9 |
Jyrkkä J et al. |
Polypharmacy status as an indicator of mortality in an elderly population.
|
|
10 |
Keränen T, Holopainen I. |
Epilepsialääkkeiden vaikutusmekanismit ja kliininen käyttö.
|
|
11 |
Keränen T et al. |
Long-term retention rate of pramipexole in the treatment of Parkinson's disease.
|
|
12 |
Kärkkäinen S et al. |
Teaching about intoxicating substances in primary school: teacher students' thoughts on the subject.
|
|
13 |
Laine JE et al. |
Acetaminophen bioactivation by human cytochrome P450 enzymes and animal microsomes.
|
|
14 |
Laitinen K. |
Onko vaihdevuosien hormonihoito turvallista?
|
|
15 |
Laitinen K, Tacke U. |
Saako pään sekaisin itsehoitolääkkeillä?
|
|
16 |
Myllynen P et al. |
Developmental expression of drug metabolizing enzymes and transporter proteins in human placenta and fetal tissues.
|
|
17 |
Myöhänen TT et al. |
Issues about the physiological functions of prolyl oligopeptidase based on its discordant spatial association with substrates and inconsistencies among mRNA, protein levels, and enzymatic activity.
|
|
18 |
Myöhänen TT et al. |
Localization of prolyl oligopeptidase in the thalamic and cortical projection neurons: A retrograde neurotracing study in the rat brain.
|
|
19 |
Oksman M et al. |
Behavioural and neurochemical response of alpha-synuclein A30P transgenic mice to the effects of L-DOPA.
|
|
20 |
Partanen HA et al. |
Aflatoxin B1 transfer and metabolism in human placenta.
|
|
21 |
Pelkonen O et al. |
From known knowns to known unknowns: predicting in vivo drug metabolites.
|
|
22 |
Rahnasto M. |
Development of Inhibitors of the Human CYP2A6 Enzyme. in vitro and in silico Study.
|
|
23 |
Rudin CM et al. |
Lung cancer in never smokers: molecular profiles and therapeutic implications.
|
|
24 |
Stenman SM et al. |
Enzymatic detoxification of gluten by germinating wheat proteases: Implications for new treatment of celiac disease.
|
|
25 |
Storvik M et al. |
5-HT(1A) receptors in the frontal cortical brain areas in Cloninger type 1 and 2 alcoholics measured by whole-hemisphere autoradiography.
|
|
26 |
Suuronen K. |
Metalworking fluids - allergens, exposure, and skin and respiratory effects.
|
|
27 |
Tacke U, Laitinen K. |
Mikä ihmeen "seksihuume" MDPV?
|
|
28 |
Tacke U et al. |
A pilot study about the feasibility and cost-effectiveness of electronic compliance monitoring in substitution treatment with buprenorphine-naloxone combination.
|
|
29 |
Tampio M et al. |
Induction of PUMA-A and down-regulation of PUMA-B expression is associated with benzo(a)pyrene-induced apoptosis in MCF-7 cells.
|
|
30 |
Uosukainen H, Laitinen K. |
Miten opioidiriippuvuutta hoidetaan?
|
|
31 |
Vähäkangas K, Myllynen P. |
Drug transporters in the human blood-placental barrier.
|